European Medicines Agency approves the use of Pfizer-BioNTech Covid-19 jab for children aged 12 to 15, making it the first vaccine to get the green light for children in the bloc
European Medicines Agency said the Pfizer-BioNTech coronavirus vaccine was"well-tolerated" in adolescents and that there were"no major concerns" in terms of side effects.
The vaccine was "well tolerated" in adolescents and there were no "major concerns" in terms of side effects, the Amsterdam-based European Medicines Agency said on Friday. "Beyond the decisions of governments, this is ultimately a decision to be made by parents for their children," she said on Twitter.
"From a safety perspective, the vaccine was well tolerated and the side effects in this age group were very much similar to what we have seen in young adults and not raising major concerns at this point in time," Cavaleri said. US authorities have also reported a small number of reports of heart inflammation among some younger people who Pfizer and Moderna, which uses the same Messenger RNA technology.BioNTech CEO and co-founder Ugur Sahin hailed Friday's decision as "another critical milestone in our collective effort to broaden vaccination programmes to as many people as possible".